With Ripple (XRP) heading towards critical price levels in October 2025, investors are looking beyond short-term bull cycles for altcoins that have more growth potential. While XRP remains a leading player in cross-border payments, Mutuum Finance (MUTM) is emerging as an alternative to watch under $1. Mutuum Finance is also causing ripples as a deserving […]With Ripple (XRP) heading towards critical price levels in October 2025, investors are looking beyond short-term bull cycles for altcoins that have more growth potential. While XRP remains a leading player in cross-border payments, Mutuum Finance (MUTM) is emerging as an alternative to watch under $1. Mutuum Finance is also causing ripples as a deserving […]

Ripple (XRP) Price Prediction, Key Levels to Watch and the Best Alternative Crypto to Buy in October 2025

2025/09/29 19:00
4 min read

With Ripple (XRP) heading towards critical price levels in October 2025, investors are looking beyond short-term bull cycles for altcoins that have more growth potential. While XRP remains a leading player in cross-border payments, Mutuum Finance (MUTM) is emerging as an alternative to watch under $1. Mutuum Finance is also causing ripples as a deserving DeFi project. 

Having already generated over $16.52 million in presale and having over 16,640 holders backing it, the project is going fast through its phases. At $0.035, Mutuum Finance is currently in presale phase 6 and 50% sold out. MUTM’s dual lending model and rapidly expanding community make it an upside-high potential bet for investors seeking tangible growth opportunities, thus presenting itself as a better coin to compete with veterans like XRP.

XRP Weekly Outlook: Major Levels to Observe

XRP is consolidating at the moment around a good support level of $2.71, testing holders’ patience as the market seeks direction. The integral structure holds strong resistance at its all-time high of $3.64, meaning that the maintenance of the $2.71 base could be the harbinger of a breakout to the explosive upside. 

Technical analysis points out that if this level is maintained, XRP may be on the cusp of a milestone move, attracting new interest from traders and long-term investors alike. For those closely following the market, MUTM’s indecisiveness is likely to push investors to find alternate opportunities like newer DeFi Mutuum Finance that offer a new way of feeling the growth potential.

Mutuum Finance Presale Smashes Records as a DeFi Trailblazer 

Mutuum Finance is leading the way with its presale, garnering the interest of more than 16,640 investors in addition to over $16.52 million in total contributions. The project is currently at Phase 6, already 50% done, with tokens priced at $0.035 per unit for MUTM. In gratitude for its earliest fans, the team began a $100,000 giveaway to give 10 winners each $10,000 worth of MUTM tokens.

Committed to extending the frontiers of decentralized finance, Mutuum Finance employs Chainlink oracles to facilitate lending, exchange, and settlement of USD-backed tokens as well as very actively traded tokens such as ETH, MATIC, and AVAX. Additionally, the platform maintains its integrity by applying robust defense mechanisms like fallback oracle protections, composite data feeds, and decentralized exchange time-weighted averages, all geared towards delivering accurate, robust price data even in the presence of extreme market volatility.

Mutuum Finance is issuing a USD-backed stablecoin on the Ethereum blockchain. Although bear markets can strip algorithmic stablecoins, this new asset will be non-algorithmic and overcollateralized and will stabilize prices even when they are declining.

Fundamentally, Mutuum Finance is an LTV system that is risk-adjusted. Every asset has a collateral limit placed just so against the risk of the asset to lend in a more stable and balanced manner. Additional protection for users in times of unpredictable market condition, the protocol even includes a buffer reserve system where high-risk assets are given proportionally higher reserve values as additional collateral.

Why Mutuum Finance Matters 

While XRP touches crucial levels near $2.71 and eyes resistance at $3.64, the majority of investors are eyeing projects with higher growth prospects. Mutuum Finance is one such project, having raised more than $16.52 million, gained more than 16,640 holders, and tokens selling at a cheap $0.035. Backed by solid risk-adjusted lending, oracle-infused infrastructure, and future USD-backed stablecoin initiatives, MUTM is positioning itself to be one of the top-performing DeFi projects worth less than $1. Join the Mutuum Finance presale today and get on board before the next phase of significant growth sets in.

For more information regarding Mutuum Finance (MUTM) please use the following links:

Website: https://mutuum.com/

Linktree: https://linktr.ee/mutuumfinance

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.418
$1.418$1.418
-1.94%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26